Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rarg
|
ENSMUSG00000001288.8 | retinoic acid receptor, gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102246731_102246895 | Rarg | 313 | 0.786022 | -0.53 | 3.8e-05 | Click! |
chr15_102246081_102246660 | Rarg | 130 | 0.916990 | -0.50 | 1.1e-04 | Click! |
chr15_102239307_102239503 | Rarg | 4184 | 0.108553 | -0.44 | 7.8e-04 | Click! |
chr15_102243500_102243700 | Rarg | 11 | 0.950727 | 0.43 | 9.2e-04 | Click! |
chr15_102240687_102240854 | Rarg | 2819 | 0.131845 | 0.42 | 1.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_109557850_109558797 | 24.53 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr2_173152672_173153088 | 18.29 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr5_137349031_137350198 | 17.15 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr4_154881181_154881372 | 16.33 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
933 |
0.46 |
chr11_97435561_97436362 | 16.12 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr5_112001700_112002600 | 16.05 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr4_154929190_154929525 | 15.95 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr16_76319178_76320114 | 15.74 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr2_165884402_165885933 | 14.79 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr10_127662435_127663215 | 14.25 |
Gm16229 |
predicted gene 16229 |
1014 |
0.29 |
chr8_114879117_114879445 | 14.23 |
Wwox |
WW domain-containing oxidoreductase |
167114 |
0.03 |
chr2_131223682_131223845 | 14.22 |
Mavs |
mitochondrial antiviral signaling protein |
10300 |
0.1 |
chr1_75443276_75444022 | 14.21 |
Gmppa |
GDP-mannose pyrophosphorylase A |
1425 |
0.23 |
chr13_107100851_107101138 | 14.21 |
Gm31452 |
predicted gene, 31452 |
37299 |
0.14 |
chr11_53483659_53483860 | 14.10 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
3485 |
0.1 |
chr5_137530580_137532081 | 13.96 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr6_120830779_120830930 | 13.84 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
5358 |
0.15 |
chr13_37666246_37666836 | 13.56 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr11_95805814_95806002 | 13.39 |
Phospho1 |
phosphatase, orphan 1 |
18591 |
0.1 |
chr9_67025381_67025670 | 13.09 |
Tpm1 |
tropomyosin 1, alpha |
7300 |
0.18 |
chr7_142574309_142575453 | 12.95 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr11_121543239_121543804 | 12.93 |
Tbcd |
tubulin-specific chaperone d |
680 |
0.7 |
chr5_119331549_119331706 | 12.76 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
34382 |
0.21 |
chr11_32280743_32280902 | 12.56 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
2689 |
0.14 |
chr16_93365247_93365596 | 12.49 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
31 |
0.97 |
chr2_84059555_84059735 | 12.41 |
Gm13692 |
predicted gene 13692 |
25032 |
0.14 |
chr5_139196928_139197208 | 12.35 |
Sun1 |
Sad1 and UNC84 domain containing 1 |
3569 |
0.17 |
chr4_53139613_53139963 | 12.24 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
20107 |
0.2 |
chrX_7967742_7967893 | 12.16 |
Gata1 |
GATA binding protein 1 |
93 |
0.93 |
chr14_70336335_70336839 | 12.16 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr1_86595391_86595654 | 12.12 |
Cops7b |
COP9 signalosome subunit 7B |
1218 |
0.35 |
chr19_61057665_61057910 | 12.07 |
Gm22520 |
predicted gene, 22520 |
44242 |
0.12 |
chr16_32509015_32509568 | 12.06 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9680 |
0.13 |
chr11_69887304_69887493 | 11.99 |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
1019 |
0.22 |
chr7_101064633_101064988 | 11.94 |
Gm5735 |
predicted gene 5735 |
3335 |
0.2 |
chr1_180182799_180183003 | 11.89 |
Coq8a |
coenzyme Q8A |
101 |
0.96 |
chr6_55356155_55356344 | 11.85 |
Aqp1 |
aquaporin 1 |
19817 |
0.14 |
chr16_49800061_49800448 | 11.84 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr5_103741831_103742104 | 11.77 |
Aff1 |
AF4/FMR2 family, member 1 |
12195 |
0.2 |
chr5_119337927_119338125 | 11.65 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
40781 |
0.19 |
chr11_84824090_84824244 | 11.54 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
4652 |
0.13 |
chr13_93648715_93648903 | 11.51 |
Bhmt |
betaine-homocysteine methyltransferase |
10848 |
0.14 |
chr17_12185970_12186143 | 11.42 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
3865 |
0.23 |
chr6_38929161_38929494 | 11.40 |
Tbxas1 |
thromboxane A synthase 1, platelet |
10303 |
0.2 |
chr16_29973340_29973609 | 11.37 |
Gm1968 |
predicted gene 1968 |
5710 |
0.18 |
chr7_142568972_142569582 | 11.36 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr11_87126714_87127907 | 11.35 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr9_108083545_108083879 | 11.26 |
Rnf123 |
ring finger protein 123 |
366 |
0.51 |
chr18_50028238_50028565 | 11.18 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr11_95666457_95667573 | 11.11 |
Phb |
prohibitin |
5 |
0.97 |
chr4_106249419_106249586 | 10.88 |
Gm12731 |
predicted gene 12731 |
7529 |
0.16 |
chr17_79350758_79351146 | 10.88 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
2055 |
0.34 |
chr19_4891697_4891848 | 10.87 |
Bbs1 |
Bardet-Biedl syndrome 1 (human) |
5945 |
0.08 |
chr15_80159254_80159657 | 10.82 |
Mgat3 |
mannoside acetylglucosaminyltransferase 3 |
14266 |
0.11 |
chr19_55565985_55566160 | 10.77 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
175748 |
0.03 |
chr13_32968268_32968438 | 10.73 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
2850 |
0.19 |
chr19_53058802_53059220 | 10.72 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
17207 |
0.15 |
chr2_174329445_174331091 | 10.71 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr9_63757305_63758776 | 10.57 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr8_93252681_93252835 | 10.57 |
Gm45727 |
predicted gene 45727 |
1583 |
0.3 |
chr7_135722538_135722689 | 10.50 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
6252 |
0.17 |
chrX_94540282_94541447 | 10.43 |
Maged1 |
melanoma antigen, family D, 1 |
1126 |
0.39 |
chr14_69536637_69537045 | 10.34 |
Gm27174 |
predicted gene 27174 |
18491 |
0.09 |
chr7_25450023_25450174 | 10.30 |
Gm15495 |
predicted gene 15495 |
6635 |
0.11 |
chr15_85771762_85772137 | 10.28 |
Ppara |
peroxisome proliferator activated receptor alpha |
265 |
0.89 |
chr17_57228051_57228489 | 10.26 |
C3 |
complement component 3 |
134 |
0.93 |
chr4_127020948_127021345 | 10.21 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
178 |
0.91 |
chr4_134869893_134870066 | 10.21 |
Rhd |
Rh blood group, D antigen |
5443 |
0.18 |
chr9_54571273_54571435 | 10.18 |
Cib2 |
calcium and integrin binding family member 2 |
11136 |
0.16 |
chr5_137580251_137580513 | 10.13 |
Tfr2 |
transferrin receptor 2 |
1489 |
0.17 |
chr4_46410753_46411015 | 10.11 |
Hemgn |
hemogen |
2622 |
0.19 |
chr5_96162084_96163134 | 10.11 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr7_45708987_45709454 | 10.09 |
Dbp |
D site albumin promoter binding protein |
1331 |
0.17 |
chr7_17059591_17061170 | 10.08 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr19_40813987_40814138 | 10.02 |
Ccnj |
cyclin J |
17217 |
0.16 |
chr15_85669900_85671551 | 10.00 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr17_48299888_48300090 | 9.93 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
49 |
0.96 |
chr7_17027518_17028301 | 9.92 |
Ppp5c |
protein phosphatase 5, catalytic subunit |
7 |
0.96 |
chr4_132530023_132530322 | 9.92 |
Gm12999 |
predicted gene 12999 |
2515 |
0.14 |
chr16_35856803_35857099 | 9.91 |
Gm49730 |
predicted gene, 49730 |
11000 |
0.11 |
chr12_118186213_118186414 | 9.89 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
12730 |
0.25 |
chr2_163539583_163539873 | 9.88 |
Hnf4aos |
hepatic nuclear factor 4 alpha, opposite strand |
1964 |
0.23 |
chr7_103865311_103865713 | 9.87 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr2_32704329_32704531 | 9.86 |
Fpgs |
folylpolyglutamyl synthetase |
285 |
0.75 |
chr6_135166872_135167032 | 9.85 |
Hebp1 |
heme binding protein 1 |
1183 |
0.33 |
chr7_127768560_127769629 | 9.79 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr5_143625595_143625787 | 9.77 |
Cyth3 |
cytohesin 3 |
3157 |
0.24 |
chr17_83684505_83684810 | 9.76 |
Mta3 |
metastasis associated 3 |
21506 |
0.21 |
chr12_32308163_32308329 | 9.70 |
Gm33308 |
predicted gene, 33308 |
61916 |
0.1 |
chr8_111312693_111312982 | 9.66 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr11_94589805_94589967 | 9.66 |
Acsf2 |
acyl-CoA synthetase family member 2 |
11883 |
0.11 |
chr5_112302279_112302623 | 9.66 |
Tpst2 |
protein-tyrosine sulfotransferase 2 |
1445 |
0.28 |
chr8_36668335_36668486 | 9.64 |
Dlc1 |
deleted in liver cancer 1 |
54467 |
0.16 |
chr5_36724217_36724614 | 9.64 |
Gm43701 |
predicted gene 43701 |
24203 |
0.11 |
chr1_181257261_181257857 | 9.60 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr4_129572356_129572507 | 9.59 |
Lck |
lymphocyte protein tyrosine kinase |
1210 |
0.25 |
chr10_13202020_13202182 | 9.58 |
Gm47402 |
predicted gene, 47402 |
3125 |
0.24 |
chr2_133688238_133688389 | 9.57 |
Gm25258 |
predicted gene, 25258 |
103892 |
0.07 |
chr16_91537496_91537647 | 9.55 |
Gm7860 |
predicted gene 7860 |
2489 |
0.15 |
chr11_11684707_11686418 | 9.52 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr7_110156726_110157216 | 9.51 |
1600010M07Rik |
RIKEN cDNA 1600010M07 gene |
5769 |
0.16 |
chr7_123462578_123462771 | 9.51 |
Aqp8 |
aquaporin 8 |
362 |
0.87 |
chr4_132736119_132736270 | 9.34 |
Xkr8 |
X-linked Kx blood group related 8 |
3648 |
0.16 |
chr4_140683736_140683901 | 9.33 |
Gm13025 |
predicted gene 13025 |
4065 |
0.14 |
chr12_16734111_16734375 | 9.33 |
Greb1 |
gene regulated by estrogen in breast cancer protein |
5885 |
0.19 |
chr18_74729272_74729502 | 9.32 |
Myo5b |
myosin VB |
4378 |
0.22 |
chr11_105143640_105143919 | 9.31 |
Mettl2 |
methyltransferase like 2 |
6216 |
0.15 |
chr11_44528916_44529097 | 9.30 |
Rnf145 |
ring finger protein 145 |
8701 |
0.18 |
chr15_97060183_97060372 | 9.27 |
Slc38a4 |
solute carrier family 38, member 4 |
4321 |
0.32 |
chr12_105034193_105034351 | 9.25 |
Glrx5 |
glutaredoxin 5 |
944 |
0.34 |
chr5_146703309_146703463 | 9.24 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
3236 |
0.24 |
chr10_24638296_24638624 | 9.21 |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
35798 |
0.13 |
chr10_63277050_63277215 | 9.17 |
Herc4 |
hect domain and RLD 4 |
1271 |
0.32 |
chr5_96951235_96951434 | 9.16 |
Gm43144 |
predicted gene 43144 |
11037 |
0.1 |
chr8_119432614_119432809 | 9.14 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
1413 |
0.35 |
chr7_143365057_143365212 | 9.13 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
509 |
0.73 |
chr6_136857573_136857913 | 9.08 |
Art4 |
ADP-ribosyltransferase 4 |
10 |
0.95 |
chr1_170622997_170623376 | 9.05 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr1_91248083_91248238 | 9.04 |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
2144 |
0.25 |
chr4_135745695_135745912 | 9.04 |
Gm12988 |
predicted gene 12988 |
10892 |
0.12 |
chr10_60347132_60347318 | 9.03 |
Vsir |
V-set immunoregulatory receptor |
213 |
0.94 |
chr9_103475369_103475714 | 9.02 |
Gm16252 |
predicted gene 16252 |
3457 |
0.14 |
chr2_102197341_102197680 | 9.01 |
Ldlrad3 |
low density lipoprotein receptor class A domain containing 3 |
11125 |
0.18 |
chr11_74896307_74898160 | 8.99 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr7_143566118_143566297 | 8.99 |
Cars |
cysteinyl-tRNA synthetase |
1192 |
0.3 |
chr14_54383598_54383819 | 8.99 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
459 |
0.67 |
chr4_150854030_150854262 | 8.99 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
227 |
0.82 |
chr9_64049464_64049751 | 8.98 |
Gm25606 |
predicted gene, 25606 |
1111 |
0.4 |
chr14_69243791_69243976 | 8.95 |
Gm27222 |
predicted gene 27222 |
15263 |
0.1 |
chr7_83653675_83653847 | 8.94 |
Il16 |
interleukin 16 |
1564 |
0.26 |
chr10_69300015_69300290 | 8.93 |
Gm40685 |
predicted gene, 40685 |
11987 |
0.17 |
chr9_54704347_54704689 | 8.92 |
Mir5710 |
microRNA 5710 |
3795 |
0.15 |
chr16_11614396_11614547 | 8.89 |
Gm4279 |
predicted gene 4279 |
77386 |
0.1 |
chr15_7167953_7168132 | 8.85 |
Lifr |
LIF receptor alpha |
13689 |
0.25 |
chr5_125305678_125305833 | 8.85 |
Scarb1 |
scavenger receptor class B, member 1 |
1213 |
0.41 |
chr2_30185408_30185575 | 8.84 |
Spout1 |
SPOUT domain containing methyltransferase 1 |
7032 |
0.1 |
chr4_46042288_46042457 | 8.83 |
Tmod1 |
tropomodulin 1 |
3163 |
0.25 |
chr6_82760794_82760976 | 8.80 |
Gm17034 |
predicted gene 17034 |
3397 |
0.18 |
chr17_84688950_84689145 | 8.79 |
Abcg8 |
ATP binding cassette subfamily G member 8 |
5916 |
0.15 |
chr6_5189516_5189802 | 8.76 |
Pon1 |
paraoxonase 1 |
4104 |
0.23 |
chr13_23763379_23764425 | 8.73 |
H1f1 |
H1.1 linker histone, cluster member |
236 |
0.7 |
chr11_116506385_116506879 | 8.71 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr17_49436864_49437067 | 8.70 |
Mocs1 |
molybdenum cofactor synthesis 1 |
3769 |
0.25 |
chr2_38192132_38192304 | 8.69 |
Dennd1a |
DENN/MADD domain containing 1A |
24399 |
0.17 |
chr4_10874128_10874685 | 8.68 |
2610301B20Rik |
RIKEN cDNA 2610301B20 gene |
92 |
0.79 |
chr3_103215031_103215182 | 8.67 |
2410024N13Rik |
RIKEN cDNA 2410024N13 gene |
16131 |
0.13 |
chr10_128368237_128369297 | 8.65 |
Coq10a |
coenzyme Q10A |
76 |
0.91 |
chr11_77423301_77423458 | 8.65 |
Ssh2 |
slingshot protein phosphatase 2 |
31942 |
0.12 |
chr6_125380218_125380671 | 8.59 |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
349 |
0.83 |
chr16_34047647_34047931 | 8.59 |
Kalrn |
kalirin, RhoGEF kinase |
31295 |
0.17 |
chr14_79295059_79295218 | 8.56 |
Rgcc |
regulator of cell cycle |
6507 |
0.18 |
chr9_42463752_42463922 | 8.55 |
Tbcel |
tubulin folding cofactor E-like |
2376 |
0.26 |
chr6_115650835_115650986 | 8.53 |
Gm14335 |
predicted gene 14335 |
11851 |
0.11 |
chr11_109587727_109587920 | 8.53 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23609 |
0.13 |
chr5_137974804_137974955 | 8.52 |
Azgp1 |
alpha-2-glycoprotein 1, zinc |
6641 |
0.09 |
chr2_132698462_132698762 | 8.51 |
Gm14097 |
predicted gene 14097 |
89 |
0.86 |
chr13_98810686_98810846 | 8.50 |
Fcho2 |
FCH domain only 2 |
4387 |
0.14 |
chr7_132772857_132773208 | 8.47 |
Fam53b |
family with sequence similarity 53, member B |
3884 |
0.24 |
chr9_14397486_14397637 | 8.43 |
Gm47319 |
predicted gene, 47319 |
11869 |
0.11 |
chr3_137969141_137969487 | 8.42 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12216 |
0.12 |
chr4_41045397_41045556 | 8.40 |
Aqp7 |
aquaporin 7 |
28 |
0.96 |
chr13_107063669_107063832 | 8.39 |
Gm31452 |
predicted gene, 31452 |
55 |
0.97 |
chr9_103007679_103008651 | 8.38 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
11 |
0.97 |
chr6_121151774_121152091 | 8.36 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
20933 |
0.12 |
chr17_45994580_45994782 | 8.35 |
Vegfa |
vascular endothelial growth factor A |
26691 |
0.14 |
chr2_27560675_27560886 | 8.33 |
Gm13421 |
predicted gene 13421 |
20351 |
0.14 |
chr17_29385308_29385465 | 8.33 |
Fgd2 |
FYVE, RhoGEF and PH domain containing 2 |
8885 |
0.12 |
chr9_43263943_43264179 | 8.32 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
72 |
0.97 |
chr8_84588614_84588793 | 8.26 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
11791 |
0.15 |
chr19_43797245_43797399 | 8.26 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
664 |
0.65 |
chr5_143639756_143640070 | 8.26 |
Cyth3 |
cytohesin 3 |
3562 |
0.24 |
chr8_105300052_105300344 | 8.26 |
E2f4 |
E2F transcription factor 4 |
2481 |
0.09 |
chr4_134983091_134983370 | 8.24 |
Syf2 |
SYF2 homolog, RNA splicing factor (S. cerevisiae) |
52220 |
0.11 |
chr19_43767999_43768210 | 8.24 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr8_10866157_10866515 | 8.23 |
Gm32540 |
predicted gene, 32540 |
150 |
0.93 |
chr12_84151088_84151272 | 8.23 |
Pnma1 |
paraneoplastic antigen MA1 |
2691 |
0.15 |
chr6_135165263_135165457 | 8.22 |
Hebp1 |
heme binding protein 1 |
2775 |
0.16 |
chr15_80801637_80802005 | 8.20 |
Tnrc6b |
trinucleotide repeat containing 6b |
3106 |
0.28 |
chr4_132078479_132078695 | 8.19 |
Epb41 |
erythrocyte membrane protein band 4.1 |
3266 |
0.14 |
chr14_76533528_76533831 | 8.18 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
7063 |
0.2 |
chr18_74422546_74422719 | 8.18 |
Gm50168 |
predicted gene, 50168 |
1827 |
0.32 |
chr19_6969291_6970359 | 8.17 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr7_142566565_142566917 | 8.16 |
Nctc1 |
non-coding transcript 1 |
8145 |
0.1 |
chr5_121244555_121244719 | 8.14 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
24418 |
0.12 |
chr8_122685287_122685451 | 8.14 |
Gm15899 |
predicted gene 15899 |
1530 |
0.24 |
chr19_46849397_46849711 | 8.13 |
Cnnm2 |
cyclin M2 |
16106 |
0.17 |
chr9_106398083_106398486 | 8.10 |
Dusp7 |
dual specificity phosphatase 7 |
23665 |
0.09 |
chr16_88576405_88576568 | 8.10 |
Cldn8 |
claudin 8 |
13303 |
0.12 |
chr13_113442282_113442504 | 8.09 |
Gm41071 |
predicted gene, 41071 |
18506 |
0.14 |
chr11_109587926_109588077 | 8.08 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23431 |
0.13 |
chr11_58953843_58955382 | 8.07 |
H2aw |
H2A.W histone |
73 |
0.33 |
chr4_45521990_45522265 | 8.06 |
Shb |
src homology 2 domain-containing transforming protein B |
8203 |
0.15 |
chr4_6416016_6416178 | 8.05 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
7891 |
0.19 |
chr12_111353338_111354089 | 8.03 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr3_52501705_52501879 | 8.03 |
Gm30173 |
predicted gene, 30173 |
15172 |
0.23 |
chr18_20931394_20931702 | 8.03 |
Rnf125 |
ring finger protein 125 |
13077 |
0.2 |
chr1_190106720_190107128 | 8.02 |
Gm28172 |
predicted gene 28172 |
61746 |
0.11 |
chr2_78718744_78718973 | 8.00 |
Gm14463 |
predicted gene 14463 |
61429 |
0.13 |
chr3_30765394_30765560 | 7.98 |
Samd7 |
sterile alpha motif domain containing 7 |
9255 |
0.14 |
chr11_103340757_103340961 | 7.97 |
Arhgap27 |
Rho GTPase activating protein 27 |
1140 |
0.36 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 21.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
5.8 | 17.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
5.5 | 22.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.6 | 13.8 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
4.2 | 12.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
4.0 | 11.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
3.7 | 14.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.7 | 14.8 | GO:0015793 | glycerol transport(GO:0015793) |
3.7 | 11.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.3 | 9.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.2 | 9.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.1 | 3.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.1 | 9.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.0 | 9.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.0 | 8.9 | GO:0032439 | endosome localization(GO:0032439) |
2.9 | 11.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.9 | 8.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.9 | 8.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.9 | 5.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.8 | 8.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.7 | 8.1 | GO:0002432 | granuloma formation(GO:0002432) |
2.7 | 8.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.7 | 10.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.6 | 13.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.6 | 5.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.6 | 10.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.6 | 7.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.6 | 12.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.6 | 7.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.5 | 7.6 | GO:0032782 | bile acid secretion(GO:0032782) |
2.5 | 10.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
2.5 | 17.7 | GO:0015825 | L-serine transport(GO:0015825) |
2.5 | 7.6 | GO:1902896 | terminal web assembly(GO:1902896) |
2.5 | 10.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.5 | 7.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.5 | 12.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
2.5 | 10.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
2.4 | 7.3 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.4 | 7.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.4 | 12.1 | GO:0015886 | heme transport(GO:0015886) |
2.4 | 12.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
2.4 | 9.6 | GO:0008228 | opsonization(GO:0008228) |
2.4 | 19.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.4 | 7.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.4 | 9.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.4 | 4.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 7.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.4 | 16.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.3 | 9.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
2.3 | 14.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
2.3 | 6.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.3 | 4.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.3 | 4.6 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
2.3 | 6.8 | GO:0097503 | sialylation(GO:0097503) |
2.2 | 9.0 | GO:0046618 | drug export(GO:0046618) |
2.2 | 2.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.2 | 6.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.2 | 11.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
2.2 | 6.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.2 | 8.7 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
2.2 | 8.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
2.1 | 2.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
2.1 | 12.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.1 | 6.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.1 | 8.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.1 | 12.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.1 | 8.4 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
2.1 | 6.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.1 | 4.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.1 | 6.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.0 | 4.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.0 | 4.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
2.0 | 6.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.0 | 18.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.0 | 8.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.0 | 5.9 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
2.0 | 7.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.0 | 2.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.0 | 3.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.9 | 3.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.9 | 5.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.9 | 9.3 | GO:0070627 | ferrous iron import(GO:0070627) |
1.8 | 9.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.8 | 11.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
1.8 | 5.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.8 | 14.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.8 | 5.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.8 | 7.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.8 | 3.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.8 | 3.5 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.8 | 5.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.8 | 7.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.8 | 5.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.8 | 5.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.7 | 15.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.7 | 5.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.7 | 8.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.7 | 1.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.7 | 5.1 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.7 | 8.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.7 | 6.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.7 | 6.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.6 | 1.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.6 | 13.1 | GO:0019627 | urea metabolic process(GO:0019627) |
1.6 | 6.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.6 | 6.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.6 | 6.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.6 | 4.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 9.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.6 | 1.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.5 | 12.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.5 | 4.6 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.5 | 6.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.5 | 10.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.5 | 4.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.5 | 4.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.5 | 24.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.5 | 3.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.5 | 3.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.5 | 1.5 | GO:0018904 | ether metabolic process(GO:0018904) |
1.5 | 4.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.5 | 3.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
1.5 | 7.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.5 | 11.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.5 | 4.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.5 | 7.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.5 | 8.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.4 | 2.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 1.4 | GO:0003166 | bundle of His development(GO:0003166) |
1.4 | 5.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.4 | 10.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.4 | 7.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.4 | 4.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.4 | 2.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.4 | 2.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.4 | 2.8 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.4 | 8.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.4 | 8.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.4 | 9.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.4 | 5.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.4 | 1.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.4 | 4.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.4 | 5.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.4 | 5.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.4 | 2.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.4 | 4.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.3 | 2.7 | GO:0050904 | diapedesis(GO:0050904) |
1.3 | 4.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.3 | 5.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.3 | 10.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 4.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.3 | 6.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.3 | 6.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.3 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.3 | 2.6 | GO:0046697 | decidualization(GO:0046697) |
1.3 | 2.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.3 | 3.9 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.3 | 7.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.3 | 1.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.3 | 1.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.3 | 2.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.3 | 5.1 | GO:0034214 | protein hexamerization(GO:0034214) |
1.3 | 3.8 | GO:0007525 | somatic muscle development(GO:0007525) |
1.3 | 3.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 2.5 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.3 | 7.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.3 | 5.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 13.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.3 | 11.3 | GO:0042730 | fibrinolysis(GO:0042730) |
1.3 | 8.8 | GO:0060242 | contact inhibition(GO:0060242) |
1.3 | 3.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.3 | 5.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.3 | 8.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.2 | 1.2 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.2 | 3.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 2.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.2 | 1.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.2 | 4.9 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
1.2 | 8.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.2 | 1.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.2 | 2.4 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.2 | 6.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 4.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.2 | 2.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.2 | 3.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 2.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.2 | 3.6 | GO:0036166 | phenotypic switching(GO:0036166) |
1.2 | 1.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.2 | 10.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.2 | 1.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.2 | 3.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.2 | 2.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.2 | 3.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.2 | 3.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.2 | 3.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 7.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 7.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.2 | 3.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 25.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.1 | 6.9 | GO:0015671 | oxygen transport(GO:0015671) |
1.1 | 2.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.1 | 3.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.1 | 3.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.1 | 5.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.1 | 3.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.1 | 2.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.1 | 4.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 3.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.1 | 3.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 6.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 3.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.1 | 1.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.1 | 3.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.1 | 2.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.1 | 1.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
1.1 | 2.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.1 | 5.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.1 | 4.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.1 | 4.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.1 | 3.2 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 3.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 7.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.1 | 1.1 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.1 | 6.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
1.1 | 4.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.1 | 3.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.1 | 1.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.1 | 2.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.1 | 4.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.1 | 7.4 | GO:0031033 | myosin filament organization(GO:0031033) |
1.1 | 3.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.1 | 3.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.1 | 4.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.1 | 3.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 4.2 | GO:0009838 | abscission(GO:0009838) |
1.0 | 2.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 3.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.0 | 3.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.0 | 4.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.0 | 9.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 18.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.0 | 3.1 | GO:0008050 | female courtship behavior(GO:0008050) |
1.0 | 8.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.0 | 6.1 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 6.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.0 | 3.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.0 | 2.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
1.0 | 8.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.0 | 3.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.0 | 3.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.0 | 17.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.0 | 3.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.0 | 2.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.0 | 3.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.0 | 5.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.0 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.0 | 2.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) nucleobase catabolic process(GO:0046113) |
1.0 | 2.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.0 | 3.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.0 | 3.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.0 | 1.0 | GO:0070384 | Harderian gland development(GO:0070384) |
1.0 | 2.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 2.0 | GO:0010039 | response to iron ion(GO:0010039) |
1.0 | 1.0 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.0 | 2.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 1.0 | GO:0061724 | lipophagy(GO:0061724) |
1.0 | 2.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.0 | 4.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.0 | 3.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
1.0 | 3.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.0 | 3.8 | GO:0006116 | NADH oxidation(GO:0006116) |
1.0 | 4.8 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.0 | 7.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
1.0 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 3.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.9 | 3.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 3.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.9 | 2.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.9 | 3.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 1.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.9 | 1.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 12.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.9 | 2.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.9 | 0.9 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.9 | 5.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.9 | 3.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.9 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.9 | 8.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.9 | 0.9 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.9 | 3.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.9 | 4.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 3.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.9 | 0.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.9 | 2.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.9 | 3.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 3.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.9 | 2.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.9 | 4.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.9 | 0.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.9 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.9 | 5.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 1.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.9 | 0.9 | GO:0010694 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.9 | 1.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.9 | 5.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.9 | 5.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.9 | 0.9 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.9 | 5.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 4.4 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.9 | 7.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.9 | 1.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.9 | 3.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.9 | 1.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.9 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.9 | 3.4 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.9 | 0.9 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.9 | 4.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.9 | 20.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.9 | 4.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 2.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.8 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 4.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.8 | 1.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 3.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 2.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.8 | 0.8 | GO:0046499 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) S-adenosylmethioninamine metabolic process(GO:0046499) |
0.8 | 0.8 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.8 | 5.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 0.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.8 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.8 | 3.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.8 | 0.8 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 0.8 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.8 | 0.8 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.8 | 0.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.8 | 5.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 0.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.8 | 18.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.8 | 4.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.8 | 2.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.8 | 1.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 3.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.8 | 2.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.8 | 3.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 2.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.8 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 8.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 10.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.8 | 4.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.8 | 4.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.8 | 4.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.8 | 2.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.8 | 2.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.8 | 3.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.8 | 5.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.8 | 1.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 2.4 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.8 | 0.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.8 | 4.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 5.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 2.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 3.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.8 | 8.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.8 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.8 | 4.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 0.8 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.8 | 0.8 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.8 | 11.8 | GO:0051923 | sulfation(GO:0051923) |
0.8 | 2.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 3.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 4.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 1.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.8 | 1.6 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.8 | 2.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.8 | 20.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.8 | 2.3 | GO:0060556 | vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) |
0.8 | 1.5 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.8 | 9.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.8 | 0.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.8 | 5.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 1.5 | GO:0016553 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.8 | 0.8 | GO:0043366 | beta selection(GO:0043366) |
0.8 | 1.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.8 | 3.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.8 | 14.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.8 | 12.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 6.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.8 | 6.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.8 | 1.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.8 | 2.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.8 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.7 | 4.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.7 | 0.7 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 1.5 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.7 | 2.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 2.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.7 | 0.7 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.7 | 2.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.7 | 0.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.7 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.7 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 2.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.7 | 0.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.7 | 2.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 8.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.7 | 5.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.7 | 8.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.7 | 7.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.7 | 5.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 6.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.7 | 4.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 1.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.7 | 0.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.7 | 0.7 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.7 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 2.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.7 | 6.4 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.7 | 3.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 2.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 5.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.7 | 0.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.7 | 2.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 4.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.7 | 4.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.7 | 2.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 4.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 2.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 1.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.7 | 2.8 | GO:0045006 | DNA deamination(GO:0045006) |
0.7 | 9.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 6.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 4.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 10.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.7 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.7 | 2.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 3.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.7 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 5.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.7 | 3.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.7 | 4.8 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.7 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 2.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 4.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.7 | 2.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 2.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 2.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 1.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.7 | 1.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.7 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.7 | 4.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 6.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.7 | 7.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.7 | 1.3 | GO:0015819 | lysine transport(GO:0015819) |
0.7 | 5.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 9.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 3.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 3.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.7 | 2.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 0.6 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.6 | 0.6 | GO:0060375 | mast cell differentiation(GO:0060374) regulation of mast cell differentiation(GO:0060375) |
0.6 | 3.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.6 | 0.6 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.6 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 1.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 1.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 4.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.6 | 1.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 6.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.6 | 1.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 1.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 0.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.6 | 2.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 2.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.6 | 3.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.6 | 0.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 4.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 0.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 5.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 5.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 1.9 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.6 | 2.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 1.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.6 | 11.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.6 | 1.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 2.5 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.6 | 1.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.6 | 1.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.6 | 1.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 3.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 2.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 3.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 3.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.6 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.6 | 1.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.6 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 4.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 2.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.6 | 1.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 2.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.6 | 5.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 1.8 | GO:0097286 | iron ion import(GO:0097286) |
0.6 | 9.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.6 | 2.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.6 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 7.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 3.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 2.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 1.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.6 | 1.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 1.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.6 | 2.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.6 | 3.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 1.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.6 | 1.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.6 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.6 | 2.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 0.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.6 | 2.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.6 | 3.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 3.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.6 | 1.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 1.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 6.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 8.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.6 | 2.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.6 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 4.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 6.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.6 | 3.4 | GO:0050779 | RNA destabilization(GO:0050779) |
0.6 | 2.8 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.6 | 2.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 3.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 1.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.6 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 3.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.6 | 0.6 | GO:0051794 | positive regulation of hair follicle maturation(GO:0048818) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.6 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 3.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 3.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.6 | 2.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 1.1 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 1.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 1.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 2.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.5 | 7.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 1.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.5 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 4.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.5 | 3.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 1.6 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 9.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 1.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 18.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 3.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 1.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 1.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.5 | 2.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 | 2.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 1.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 0.5 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.5 | 5.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 2.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 3.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.5 | 5.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.5 | 0.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.5 | 2.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 5.7 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.5 | 2.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 0.5 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.5 | 2.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 5.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 0.5 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.5 | 1.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.5 | 1.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.5 | 1.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 8.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 9.8 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.5 | 2.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 1.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.5 | 2.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 0.5 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 3.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 3.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 3.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.5 | 2.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 2.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 1.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.5 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 0.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 1.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 1.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 7.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 4.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 1.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.5 | 1.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.5 | 1.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.5 | 17.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.5 | 3.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 2.9 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 2.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.5 | 1.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 6.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 1.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 2.9 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.5 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 13.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 3.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.5 | 4.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.5 | 3.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 3.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.5 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 4.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 5.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 1.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 4.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 1.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 2.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 2.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 0.5 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.5 | 6.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.5 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 1.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 1.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 1.9 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.5 | 0.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 4.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 0.9 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.5 | 12.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.5 | 2.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.5 | 1.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.5 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 5.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.5 | 1.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.5 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 0.9 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.5 | 0.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.5 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 1.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 1.4 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.5 | 0.5 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.5 | 2.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 3.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 0.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 2.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 0.9 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.4 | 1.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 3.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.4 | 1.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 0.4 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 0.4 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.4 | 6.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 4.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 3.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 2.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 5.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 2.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 3.8 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.4 | 1.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.4 | 0.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.4 | 2.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 1.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 2.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 2.1 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 1.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 2.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 0.4 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.4 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 0.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 1.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 2.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 1.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 4.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 3.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 1.6 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.4 | 2.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.4 | 16.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 1.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 0.8 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 1.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 2.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 4.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 0.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 2.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 0.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.4 | 1.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 2.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.4 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 0.4 | GO:1901856 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) negative regulation of cellular respiration(GO:1901856) |
0.4 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 0.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 0.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 6.9 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 2.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.4 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 1.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 0.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.4 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 1.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 10.2 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.4 | 3.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 0.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 0.7 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.4 | 2.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 1.1 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 3.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 4.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.4 | 2.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 3.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 0.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 5.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 2.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 1.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.4 | 1.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 6.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 0.7 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.4 | 1.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 4.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 4.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 1.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 1.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 13.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 5.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 1.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 3.5 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.4 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 3.9 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 1.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 1.0 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 2.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 2.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 5.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 2.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.3 | 2.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 1.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 1.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.3 | GO:0072677 | eosinophil migration(GO:0072677) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 1.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 1.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 1.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 4.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 1.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 1.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 2.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 3.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 2.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 2.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 2.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 1.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 1.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 0.6 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.3 | 0.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.3 | 2.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 2.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 1.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 1.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.0 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 0.6 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.3 | 10.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.3 | 1.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 2.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.3 | 3.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 2.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 6.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 1.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 1.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 1.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 0.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.3 | 0.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 0.9 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 2.4 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 4.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 1.8 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 2.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.3 | 0.3 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 1.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 3.0 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.3 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 1.5 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 0.3 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.3 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 0.9 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 0.3 | GO:0010452 | regulation of histone H3-K36 methylation(GO:0000414) histone H3-K36 methylation(GO:0010452) |
0.3 | 1.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 2.1 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 2.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 15.1 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.3 | 1.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 1.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 3.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 1.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 0.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 1.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.6 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.3 | 1.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.3 | 0.6 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.3 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 2.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 8.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 1.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 1.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 4.2 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.3 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 1.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.3 | 1.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 5.8 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.3 | 1.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.3 | 1.4 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.3 | 3.3 | GO:0042116 | macrophage activation(GO:0042116) |
0.3 | 1.6 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 1.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.3 | 2.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 16.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 0.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 6.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 1.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 3.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.3 | 4.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.8 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.3 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 7.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 1.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 0.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.5 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.3 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.3 | 2.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.3 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 0.3 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.3 | 1.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 2.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 2.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 1.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 1.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 1.0 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 1.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 9.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 1.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 2.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.9 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 1.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 2.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 2.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 1.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.7 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.2 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.4 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.4 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 2.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.9 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.2 | 0.4 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 2.0 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 4.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.6 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 3.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 1.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.8 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.2 | 0.2 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.2 | 0.2 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 1.9 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 2.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 1.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 1.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 5.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 2.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.7 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.7 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 4.8 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.8 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 6.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 2.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.5 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 1.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 2.1 | GO:0006949 | syncytium formation(GO:0006949) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 12.3 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 5.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 1.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.2 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 2.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 2.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 0.3 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.2 | 2.8 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 1.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 4.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 2.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 0.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.2 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 1.1 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 1.1 | GO:0048538 | thymus development(GO:0048538) |
0.2 | 0.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 3.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 3.2 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 3.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 0.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) hematopoietic stem cell migration(GO:0035701) |
0.2 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.5 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.3 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.2 | 1.7 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 4.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:1901069 | purine deoxyribonucleotide catabolic process(GO:0009155) guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 1.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 1.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.3 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 6.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.0 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.7 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 3.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 2.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.6 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 1.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 1.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 3.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 3.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.7 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 1.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.6 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.1 | 1.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.5 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.1 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 4.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 1.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 1.3 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.7 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.7 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 2.7 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.5 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 1.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.3 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 1.5 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 1.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 1.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 1.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 1.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.9 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.4 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 7.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.1 | GO:0072376 | protein activation cascade(GO:0072376) |
0.1 | 1.0 | GO:0097530 | granulocyte migration(GO:0097530) |
0.1 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.9 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.3 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 2.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) positive regulation by host of viral process(GO:0044794) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 3.6 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 1.0 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.0 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.0 | 0.0 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 4.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.4 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.0 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 6.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 1.0 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.0 | 0.0 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.0 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 1.6 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.6 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.3 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 6.4 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.1 | GO:0010894 | negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.6 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.0 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 1.6 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.0 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 12.7 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 17.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.4 | 10.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.3 | 13.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
3.3 | 9.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.2 | 9.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.1 | 9.4 | GO:1990635 | proximal dendrite(GO:1990635) |
3.1 | 9.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
3.0 | 9.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.9 | 11.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.6 | 18.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.6 | 10.3 | GO:0072487 | MSL complex(GO:0072487) |
2.5 | 12.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.5 | 7.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.3 | 9.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.2 | 15.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.9 | 5.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 5.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.8 | 1.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.8 | 10.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.7 | 5.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.7 | 3.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.6 | 1.6 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
1.6 | 7.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.6 | 12.6 | GO:0030056 | hemidesmosome(GO:0030056) |
1.6 | 7.8 | GO:0031983 | vesicle lumen(GO:0031983) |
1.5 | 10.8 | GO:0042627 | chylomicron(GO:0042627) |
1.5 | 7.5 | GO:0000235 | astral microtubule(GO:0000235) |
1.5 | 6.0 | GO:1990130 | Iml1 complex(GO:1990130) |
1.5 | 20.8 | GO:0031528 | microvillus membrane(GO:0031528) |
1.5 | 5.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.5 | 11.7 | GO:0045179 | apical cortex(GO:0045179) |
1.5 | 5.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.4 | 5.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.4 | 8.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 4.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.4 | 14.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.3 | 7.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 3.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 3.8 | GO:0097413 | Lewy body(GO:0097413) |
1.3 | 7.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.2 | 13.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 8.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 5.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 4.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.2 | 5.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 17.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 4.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.1 | 4.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 5.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 15.3 | GO:0000974 | Prp19 complex(GO:0000974) |
1.1 | 7.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.1 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.0 | 8.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.0 | 9.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 4.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 6.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.0 | 4.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 3.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.0 | 2.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 28.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.0 | 3.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 9.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 11.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.0 | 14.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.0 | 1.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 4.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.9 | 8.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 82.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 6.4 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 3.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.9 | 4.5 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 10.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.9 | 3.5 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 2.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.9 | 4.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 3.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 6.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 3.4 | GO:0035363 | histone locus body(GO:0035363) |
0.9 | 3.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.8 | 0.8 | GO:0005818 | aster(GO:0005818) |
0.8 | 7.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 2.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.8 | 5.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.8 | 2.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 2.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.8 | 5.7 | GO:0000243 | commitment complex(GO:0000243) |
0.8 | 12.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 3.2 | GO:0071437 | invadopodium(GO:0071437) |
0.8 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.8 | 10.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.8 | 8.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.8 | 3.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 3.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.7 | 2.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 13.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.7 | 2.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 4.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 4.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 23.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 5.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 46.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 2.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 13.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 5.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.7 | 6.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 30.5 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 2.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 6.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.7 | 7.3 | GO:0032039 | integrator complex(GO:0032039) |
0.7 | 3.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 22.0 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 3.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 0.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.6 | 2.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 7.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 1.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 1.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 1.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.6 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 3.0 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 45.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 1.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 4.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 7.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 31.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.6 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 1.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 4.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 1.7 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 3.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.6 | 4.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 2.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 6.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 3.2 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 7.9 | GO:0043034 | costamere(GO:0043034) |
0.5 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 3.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.5 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 27.9 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 20.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 3.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 5.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 3.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 2.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 16.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 3.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 1.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 6.8 | GO:0031430 | M band(GO:0031430) |
0.5 | 3.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 3.8 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 22.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 23.0 | GO:0005903 | brush border(GO:0005903) |
0.5 | 3.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 3.7 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 6.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 1.8 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 3.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.5 | 0.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 10.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 12.1 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 13.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.4 | 3.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 2.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 8.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 4.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 9.1 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 1.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.4 | 3.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 7.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 2.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 4.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 12.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 7.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 2.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 8.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 2.5 | GO:0000801 | central element(GO:0000801) |
0.4 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 13.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 3.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 8.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 3.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 15.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 4.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 0.4 | GO:1904949 | ATPase complex(GO:1904949) |
0.4 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 4.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 3.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 14.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.4 | 4.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 2.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 2.9 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 0.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 1.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.7 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 5.2 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 3.8 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 3.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 9.0 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 2.0 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.3 | 14.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 0.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 2.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 40.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 1.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 11.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 6.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 4.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 39.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 3.7 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 5.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 2.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 8.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.5 | GO:0030894 | replisome(GO:0030894) |
0.3 | 1.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 2.3 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.3 | 4.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 2.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 2.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 2.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 5.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 2.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.3 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 9.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 31.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 6.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 2.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 2.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 0.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 1.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 2.1 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 2.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 2.8 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.3 | 0.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 0.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.3 | 0.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 16.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 7.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 12.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 9.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 9.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 5.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 2.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 3.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 4.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 68.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 17.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 3.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 9.3 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 2.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.7 | GO:0043230 | extracellular organelle(GO:0043230) |
0.2 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 7.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 4.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.4 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 7.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 20.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 12.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 2.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.2 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.3 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 29.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 2.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.2 | 10.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 19.5 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.8 | GO:0005819 | spindle(GO:0005819) |
0.2 | 14.4 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 291.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 2.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 3.0 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.3 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 5.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 113.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 3.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 98.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 5.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 87.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 5.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.4 | GO:0031975 | envelope(GO:0031975) |
0.1 | 0.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.8 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 2.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 3.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 15.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 2.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 3.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 1.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 5.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 6.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
4.3 | 12.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
4.2 | 12.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.1 | 12.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.7 | 11.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.6 | 14.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.4 | 20.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
3.3 | 16.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.2 | 12.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
2.8 | 11.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
2.8 | 11.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.7 | 8.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.7 | 21.7 | GO:0008430 | selenium binding(GO:0008430) |
2.7 | 10.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.7 | 10.7 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 7.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.5 | 10.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.5 | 7.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.4 | 9.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.4 | 11.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.2 | 6.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.2 | 6.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.2 | 8.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.1 | 8.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.1 | 6.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 8.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.0 | 8.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.0 | 17.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.0 | 9.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
2.0 | 5.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 5.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.9 | 7.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.9 | 16.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.9 | 5.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.8 | 5.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.8 | 10.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.8 | 5.3 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 1.8 | GO:0034618 | arginine binding(GO:0034618) |
1.7 | 5.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.7 | 6.9 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.7 | 6.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.7 | 5.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.7 | 6.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.6 | 4.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.6 | 21.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.6 | 4.8 | GO:0048030 | disaccharide binding(GO:0048030) |
1.6 | 1.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.5 | 4.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.5 | 10.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 4.6 | GO:0050692 | DBD domain binding(GO:0050692) |
1.5 | 4.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 4.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.5 | 7.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.5 | 4.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.5 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.5 | 10.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.5 | 7.4 | GO:0031013 | troponin I binding(GO:0031013) |
1.5 | 5.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.5 | 32.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 7.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.5 | 5.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.5 | 5.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.4 | 7.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 7.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.4 | 5.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.4 | 4.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.4 | 16.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.4 | 4.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.4 | 4.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.4 | 2.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.4 | 8.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.3 | 4.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.3 | 4.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.3 | 1.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.3 | 12.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.3 | 2.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 3.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.3 | 3.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.3 | 5.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.3 | 3.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.2 | 3.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.2 | 3.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.2 | 3.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 19.4 | GO:0001848 | complement binding(GO:0001848) |
1.2 | 6.0 | GO:0046790 | virion binding(GO:0046790) |
1.2 | 4.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.2 | 6.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.2 | 3.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.2 | 3.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.2 | 5.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.2 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.2 | 21.0 | GO:0008483 | transaminase activity(GO:0008483) |
1.2 | 5.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.1 | 1.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.1 | 20.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.1 | 3.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.1 | 5.6 | GO:0070061 | fructose binding(GO:0070061) |
1.1 | 5.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.1 | 6.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.1 | 6.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.1 | 7.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.1 | 2.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.1 | 3.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.1 | 3.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.1 | 3.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.1 | 16.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.1 | 2.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.1 | 7.4 | GO:1990405 | protein antigen binding(GO:1990405) |
1.0 | 5.2 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 4.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 5.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.0 | 3.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.0 | 3.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 12.2 | GO:0015643 | toxic substance binding(GO:0015643) |
1.0 | 4.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 3.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.0 | 4.0 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 5.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 5.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 3.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.0 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 2.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 2.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 7.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.0 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 4.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 5.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 3.9 | GO:0038100 | nodal binding(GO:0038100) |
1.0 | 13.5 | GO:0008143 | poly(A) binding(GO:0008143) |
1.0 | 2.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.0 | 3.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.0 | 11.5 | GO:0044548 | S100 protein binding(GO:0044548) |
1.0 | 3.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 3.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 2.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 2.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 0.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.9 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.9 | 2.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 3.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.9 | 16.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.9 | 3.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 18.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 15.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 2.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 9.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.9 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.9 | 4.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.9 | 3.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 8.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.9 | 2.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.9 | 2.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 3.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 0.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.9 | 1.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.9 | 5.5 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.9 | 8.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.9 | 2.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 7.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 7.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 3.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.9 | 6.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.9 | 5.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.9 | 7.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 2.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 2.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 9.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.9 | 6.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.9 | 5.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.9 | 2.6 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 7.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.9 | 3.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 1.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 3.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 2.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 0.9 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.8 | 2.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 8.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.8 | 5.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.8 | 4.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 4.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 2.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.8 | 5.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.8 | 9.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 3.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.8 | 1.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 5.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 4.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 3.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.8 | 2.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.8 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 3.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 2.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.8 | 1.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 6.3 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.8 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 24.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.8 | 7.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 0.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.8 | 23.1 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.8 | 3.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 3.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 8.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 0.8 | GO:0015665 | polyol transmembrane transporter activity(GO:0015166) alcohol transmembrane transporter activity(GO:0015665) |
0.8 | 3.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 0.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 9.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 3.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.7 | 3.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 3.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 2.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 2.2 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 2.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 5.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 2.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 9.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.7 | 3.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 10.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 1.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 2.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 7.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 9.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 2.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 5.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 2.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 4.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 3.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 5.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 13.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 9.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.7 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 28.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.7 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 18.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.7 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 2.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.7 | 6.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 5.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 6.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 5.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.7 | 2.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 1.3 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.6 | 3.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 5.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 9.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 19.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.6 | 1.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.6 | 7.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 1.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 8.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.6 | 2.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 5.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 5.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 1.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.6 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 10.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 2.3 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.6 | 4.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 1.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 0.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 1.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.6 | 1.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 5.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 17.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 9.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 2.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 1.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 0.6 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.6 | 18.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.6 | 1.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 1.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 3.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 1.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.5 | 2.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 3.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 10.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 2.1 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.5 | 47.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 1.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 1.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.5 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 5.9 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.5 | 3.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 4.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 6.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 2.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 1.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 3.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 5.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 2.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 9.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 15.7 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.5 | 6.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 4.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.5 | 1.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 55.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 2.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.5 | 10.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.5 | 1.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 7.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.5 | 11.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 2.0 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 3.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 6.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 10.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 7.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 2.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 1.5 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 2.0 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 1.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 1.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 1.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 2.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 5.3 | GO:0008061 | chitin binding(GO:0008061) |
0.5 | 1.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 2.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 2.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 3.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 0.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 2.4 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.5 | 5.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 4.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 91.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.5 | 1.8 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 3.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 4.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.5 | 1.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.5 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 2.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 2.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 2.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 2.2 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 21.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 16.4 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.4 | 0.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 4.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 5.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 4.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 2.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 2.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 2.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.4 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 2.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.4 | 3.9 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 1.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 3.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 3.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 8.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 1.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 15.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 3.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 0.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 11.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 2.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 2.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.4 | 5.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 7.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 4.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 4.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 15.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 11.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 2.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 4.7 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.4 | 56.6 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.4 | 3.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 11.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.4 | 3.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 1.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 15.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 0.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 0.4 | GO:0022884 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.4 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 2.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 3.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 4.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 4.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 3.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 2.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 3.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 6.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 2.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 3.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 1.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 3.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.3 | GO:0030523 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.3 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 18.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 7.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 3.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 3.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 4.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.3 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 2.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 10.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 4.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 26.0 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 2.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 4.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 1.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 2.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 13.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 4.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 13.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 6.7 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 1.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.3 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 1.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 13.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 0.3 | GO:0019238 | GTP cyclohydrolase activity(GO:0003933) cyclohydrolase activity(GO:0019238) |
0.3 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 1.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 0.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 12.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 6.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 3.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.3 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.3 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 5.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 4.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 42.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 2.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 25.6 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 3.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 2.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 3.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 9.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 1.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 6.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 4.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 2.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 4.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 6.0 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 29.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 2.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 4.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 3.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 2.3 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 2.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 13.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 1.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 10.7 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 2.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.2 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 35.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 3.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 23.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 1.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 7.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 1.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 4.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 1.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.4 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 2.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 13.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 2.7 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.8 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 8.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 10.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 2.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 2.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.5 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 1.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 4.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 1.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.4 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 1.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.4 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 22.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.4 | 24.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.4 | 18.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.3 | 34.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.2 | 21.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.2 | 4.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.1 | 48.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 30.3 | PID IGF1 PATHWAY | IGF1 pathway |
1.1 | 22.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 30.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 14.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.9 | 12.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 9.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 22.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 5.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 9.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 17.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 3.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 1.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 41.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 5.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 4.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 2.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 3.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 27.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 6.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 7.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 7.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 12.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 25.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 3.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 9.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 22.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 24.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 51.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 10.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 10.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 3.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 18.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 5.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 6.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 12.4 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 3.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 3.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 10.6 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 11.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 2.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 13.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 9.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 5.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 1.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 12.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 3.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 2.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 1.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 3.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 3.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 8.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 13.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 9.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 2.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 2.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 4.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 3.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 13.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 4.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 2.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 2.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 4.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 6.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 2.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 2.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 3.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 3.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 4.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 4.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 6.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 2.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 3.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 4.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
3.1 | 24.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.5 | 25.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.3 | 23.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.2 | 26.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.2 | 2.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.0 | 22.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.9 | 5.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.9 | 5.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.7 | 27.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 16.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.6 | 47.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.4 | 17.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 13.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.3 | 3.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.3 | 24.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 13.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.2 | 5.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 10.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 20.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.1 | 21.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.1 | 6.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.1 | 18.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.1 | 17.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.1 | 4.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.0 | 10.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 11.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.0 | 15.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.0 | 11.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.0 | 18.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 3.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.0 | 14.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.0 | 2.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.9 | 5.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.9 | 9.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 14.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.9 | 13.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 7.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 9.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.9 | 24.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 15.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.9 | 9.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 40.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 7.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 6.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.8 | 3.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.8 | 7.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.8 | 5.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 9.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.7 | 4.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 16.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.7 | 5.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.7 | 10.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 8.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 13.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 8.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 8.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 7.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.7 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 9.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 4.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.7 | 4.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.7 | 5.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 15.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.7 | 1.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.7 | 9.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 11.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.6 | 8.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.6 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 2.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 6.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 4.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 13.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 7.7 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.6 | 4.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 4.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 7.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.6 | 4.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 8.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.6 | 9.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 6.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 1.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.6 | 47.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 1.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 16.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 7.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 13.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 4.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 18.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 3.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.5 | 0.5 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.5 | 5.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 3.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 10.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 10.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 8.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.5 | 4.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 11.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 3.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 3.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 12.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 27.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.5 | 9.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 3.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 13.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 7.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 3.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.5 | 5.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 14.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 1.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 5.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 5.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 9.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 2.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 5.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 2.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 19.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 8.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.4 | 1.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 10.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 2.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 7.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 18.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 3.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 1.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 3.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 2.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 25.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 53.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 2.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 3.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 7.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 2.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 6.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 15.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 8.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.3 | 6.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 1.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 3.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.3 | 12.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 3.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 1.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 27.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 12.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 1.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 6.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 3.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 1.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 2.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 5.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 3.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 3.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 3.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 2.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 6.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 9.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 3.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 4.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 2.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 4.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 4.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.6 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 7.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |